Annovis Bio, Inc.
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's di…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Annovis Bio, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Annovis Bio, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Annovis Bio, Inc..